Cognic Systems

Home / Industries / Pharma & Life Sciences / Pharmacovigilance Platform
AI ADVERSE EVENT INTAKE & SIGNAL DETECTION

Pharmacovigilance Software Platform (Solution #1046)

End-to-end drug safety intelligence automating unstructured adverse event extraction, MedDRA medical coding, literature screening, and global regulatory submissions.

65%
Case Processing Time Cut
99.4%
MedDRA Auto-Coding Accuracy
Zero
Late Regulatory Safety Filings
AEO DIRECT CAPSULE — AT A GLANCE

Pharmacovigilance Software Platform by Cognic automates post-marketing and clinical drug safety operations. Powered by specialized medical NLP, it extracts adverse events from literature, social feeds, and medical records, executes automated MedDRA coding, and submits compliant E2B(R3) ICSR reports to global authorities.

Regulatory Formats
ICH E2B(R3), FDA FAERS, EMA EudraVigilance, PMDA
Medical Vocabularies
MedDRA (LLT, PT, HLT, HLGT, SOC), WHO-DD, SNOMED CT
Signal Analytics
Disproportionality Scores (PRR, ROR, EBGM, MGPS)
Deployment
Validated GxP Cloud / Part 11 Certified Multi-Tenant
CHALLENGES SOLVED

Critical Operational Bottlenecks in Life Sciences

Strict GxP compliance hurdles, fragmented clinical datasets, and manual cleanroom workflows slow development and inflate operational risk.

01

Explosion of Unstructured Adverse Event Data

Safety teams are overwhelmed by thousands of adverse event reports flooding in via medical call centers, patient portals, scientific literature, and social media.

02

Manual, Error-Prone Medical Coding and Case Narrative Drafting

Manually looking up MedDRA terms and typing Individual Case Safety Report (ICSR) narratives consumes hours per case, increasing the risk of late regulatory filings.

03

Delayed Safety Signal Detection in Post-Market Drugs

Failing to detect subtle adverse event frequency spikes across millions of health records exposes patients to harm and pharma companies to severe regulatory penalties.

ENGINEERING CAPABILITIES

Architectural Foundation of Our Pharma Solution

Engineered for validated GxP environments with 21 CFR Part 11 audit trails, data integrity, and enterprise integration.

Multi-Channel Adverse Event Intake AI

Extracts patient identifiers, suspect drugs, adverse reactions, and reporter details from PDFs, audio call recordings, emails, and medical literature.

Automated MedDRA & WHO-DD Medical Coding

Maps natural language symptoms directly to lowest level terms (LLT) and preferred terms (PT) with contextual confidence scores.

Automated E2B(R3) Case Generation & Submission

Validates mandatory ICH data fields, checks for duplicate cases, and dispatches encrypted XML safety reports directly to FDA and EMA gateways.

Statistical Safety Signal Detection

Applies proportional reporting ratio (PRR) and Bayesian empirical Bayes geometric mean (EBGM) algorithms to identify emerging safety risks.

FEATURE BREAKDOWN

Core Technical Features & Capabilities

Purpose-built software components supporting pharmaceutical researchers, quality managers, and manufacturing engineers.

Biomedical LLM Case Narrative Generation

Drafts coherent, standardized clinical case narratives automatically from fragmented physician notes and patient questionnaire data.

Automated Medical Literature Screening

Continuously scans PubMed, Embase, and local medical journals to detect and triage potential adverse drug reaction (ADR) publications.

Causality Assessment Scoring (Naranjo & WHO-UMC)

Guides drug safety officers through structured causality questionnaires to establish drug-event relationship probabilities.

Periodic Safety Update Reports (PSUR/PBRER)

Aggregates case counts, exposure data, and benefit-risk evaluations into automated periodic regulatory safety review documents.

Duplicate Case Detection & Merge Engine

Uses fuzzy patient matching, birthdates, and reaction dates to detect duplicate reports received across multiple reporting channels.

FDA FAERS & EMA EudraVigilance Gateway Integration

Connects directly via AS2 secure file transfer protocols, tracking electronic acknowledgments (ACK) automatically in the audit trail.

MEASURABLE OUTCOMES

Quantifiable Operational Impact

Field-proven ROI metrics achieved across global pharmaceutical sponsors, biotechs, and contract manufacturers.

-65%
Adverse Event Case Processing Time
100%
On-Time Expedited 7/15-Day Submissions
99.4%
Medical Terminology Auto-Coding Accuracy
-50%
Safety Operations Department Cost
SYSTEM ARCHITECTURE

End-to-End Pharmaceutical Data Pipeline

From cleanroom instrument telemetry and clinical EDC capture to validated cloud analytics and regulatory filings.

Stage 01

Multi-Source AE Ingestion & OCR

Ingests adverse event source files from clinical trials, medical inquiry forms, call center audios, and scientific journal RSS feeds.

Stage 02

Entity Extraction & MedDRA Auto-Coding

Named entity recognition (NER) models extract patient demographics, concomitant medications, and codify reactions to MedDRA PTs.

Stage 03

Triage, Duplicate Check & Medical Review

System scores case seriousness (death, hospitalization, disability) and presents high-confidence suggestions for physician review.

Stage 04

Regulatory XML Packaging & Gateway Dispatch

Compiles validated ICH E2B(R3) XML packets and transmits them directly to regulatory authority gateways with digital signatures.

TECHNOLOGY STACK

Validated Technologies & Protocols

Engineered with modern, open standards that integrate directly with enterprise ERPs, LIMS, and regulatory submission gateways.

Clinical NLP & AI
BioBERT, SciSpacy, HuggingFace, Custom MedDRA Transformers
Regulatory Gateways
ICH E2B(R3) Validator, AS2 Protocol, XML Schema Engines
Data Architecture
PostgreSQL, Elasticsearch, Redis, Node.js, TypeScript
Compliance & Audit
FDA 21 CFR Part 11, GxP Audit Vault, OAuth 2.0 / SAML
PROVEN CUSTOMER SUCCESS

Global Pharmaceutical Manufacturer with 12 Commercial Brands (London, UK)

The Challenge

A 200% surge in post-marketing adverse event volume led to a 6-week case processing backlog and serious risk of missing mandatory 15-day EMA reporting deadlines.

The Architectural Solution

Deployed Cognic Pharmacovigilance Software Platform with automated AI adverse event extraction, MedDRA auto-coding, and E2B(R3) direct submission.

Verified Operational Results
Eliminated the 6-week case processing backlog in under 30 days
Reduced manual ICSR case handling time from 45 minutes to 14 minutes per case
Maintained a 100% on-time submission rate for all 7-day and 15-day regulatory safety reports
FREQUENTLY ASKED QUESTIONS

Technical & Regulatory Insights

Key architectural, compliance, and deployment details about our Pharmacovigilance Platform software platform.

What is a pharmacovigilance platform?
A pharmacovigilance platform manages the collection, detection, assessment, and prevention of adverse drug effects. It standardizes safety data intake, codifies medical terms using MedDRA, detects safety signals, and submits regulatory reports to agencies like the FDA and EMA.
What is the ICH E2B(R3) reporting standard?
ICH E2B(R3) is the international data standard for electronic transmission of Individual Case Safety Reports (ICSRs). The platform structures patient, drug, and adverse reaction data into standardized XML formats required by global health authorities.
How does AI automate MedDRA coding?
Specialized biomedical NLP models analyze verbatim symptom descriptions in patient reports, automatically matching them to the most accurate MedDRA Lowest Level Term (LLT) and Preferred Term (PT), alerting safety officers if human review is needed.
How does statistical signal detection work?
The platform applies statistical disproportionality algorithms (including PRR and EBGM) to compare adverse event reporting rates against background drug populations, highlighting potential safety concerns that warrant immediate investigation.
Can the software ingest adverse events from social media and medical literature?
Yes. The system continuously screens scientific databases (like PubMed) and public digital channels, filtering out noise and extracting relevant adverse event mentions for review and verification by safety professionals.

Ready to Transform Your Life Sciences Operations?

Speak with Cognic Systems principal pharmaceutical software architects to discuss GxP validation, clinical AI pipelines, and manufacturing execution systems.